14670-94-1

Basic information

• Product Name: 3,5-DIMETHYLADAMANTANE-1-CARBOXYLIC ACID
• Synonyms: 1,3-DIMETHYLADAMANTAN-5-CARBOXYLIC ACID;3,5-DIMETHYLADAMANTANE-1-CARBOXYLIC ACID;3,5-DIMETHYL-1-ADAMANTANE CARBOXYLIC ACID;AKOS B019696;AKOS BC-0371;CHEMBRDG-BB 4013910;ART-CHEM-BB B019696;3,5-dimethyladamantane-1-carboxylic acid(SALTDATA: FREE)
• CAS NO: 14670-94-1
• Molecular Formula: C₁₃H₂₀O₂
• Molecular Weight: 208.3
• Product Categories: Adamantane derivatives;chiral
• Mol File: 14670-94-1.mol
• Article Data: 5

Chemical Properties

• Melting Point: 89-90°C
• Boiling Point: 324.1 °C at 760 mmHg
• Flash Point: 153.9 °C
• Appearance: white to light yellow crystal powder
• Density: 1.183±0.06 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 5.1E-05mmHg at 25°C
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: Sparingly Soluble (0.14 g/L) (25°C)
• PKA: 4.88±0.60(Predicted)
• CAS DataBase Reference: 3,5-DIMETHYLADAMANTANE-1-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-DIMETHYLADAMANTANE-1-CARBOXYLIC ACID(14670-94-1)
• EPA Substance Registry System: 3,5-DIMETHYLADAMANTANE-1-CARBOXYLIC ACID(14670-94-1)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22
• Safety Statements: 24/25
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 14670-94-1(Hazardous Substances Data)

Usage

Chemical Properties

white to light yellow crystal powde

Uses

3,5-Dimethyladamantane-1-carboxylic acid, is used as a pharmaceutical and API intermediate.

InChI:InChI=1/C13H20O2/c1-11-3-9-4-12(2,6-11)8-13(5-9,7-11)10(14)15/h9H,3-8H2,1-2H3,(H,14,15)/p-1/t9?,11-,12+,13?

Upstream product

• 64-18-6 formic acid 
• 941-37-7 3,5-dimethyl-1-bromoadamantane 
• 702-79-4 1,3-dimethyladamantane 
• 707-37-9 1,3-dimethyl-5-adamantanol 
• 26919-42-6 (3,5-dimethyl-adamantan-1-yl)-methanol 
• 101821-77-6 3,5-dimethyladamantan-1-yl nitrate 

Downstream Products

• 26919-42-6 (3,5-dimethyl-adamantan-1-yl)-methanol 
• 40430-57-7 3, 5-dimethyl-1-adamantyl methyl ketone 
• 19982-07-1 1-acetamido-3,5-dimethyladamantane 

Relevant articles and documents

Novel rimantadine analog and synthetic method thereof

The invention provides a novel rimantadine analog. The novel rimantadine analog has a structure shown in formula (I). The rimantadine analog has high activity and is more beneficial to clinical use and further development and research of drugs.

Enantioselective borohydride reduction of aliphatic ketones catalyzed by ketoiminatocobalt(iii) complex with 1-chlorovinyl axial ligand

For the enantioselective borohydride reduction of aliphatic ketones, the optically active ketoiminatocobalt(II) catalysts was successfully designed based on their axial ligand. Instead of chloroform for the aryl ketone reduction, various axial ligand precursors were examined for the aliphatic ketone. Consequently, 1, 1, 1-trichloroethane was found to be the most effective activator of the cobalt(II) complexes to generate the corresponding 1-chlorovinyl cobalt(III) derivatives as the reactive intermediate. Several aliphatic ketones were successfully reduced to afford the corresponding secondary alcohols with high enantioselectivities.

ADAMANTANOL NITRATES IN NUCLEOPHILIC SUBSTITUTION REACTIONS

-